Related Experiment Video
Updated: Jan 22, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Vaccine expression systems and maternal/neonatal factors: Impacts on hepatitis B immunization efficacy in preterm
Lu Shen1, Yan Xie1, Zhongkui Zhu1
1Department of Expanded Programme on Immunization, Taizhou City Center for Disease Control and Prevention, Taizhou, Jiangsu, China.
Insights
Hepatitis B vaccination is highly effective in preterm infants, achieving 99.43% seroprotection. Factors like gestational age and vaccine schedules influence antibody levels, guiding future infant immunization strategies.
Area of Science:
- Neonatal immunology
- Vaccinology
- Public health
Background:
- Global increase in preterm births necessitates effective hepatitis B prevention strategies.
- Hepatitis B vaccination is recommended for preterm infants, but immunogenicity requires further study.
Purpose of the Study:
- To assess the immunogenicity of hepatitis B vaccination in preterm infants.
- To identify factors influencing antibody response, including gestational age and immunization protocols.
Main Methods:
- Analysis of 699 preterm infants completing the hepatitis B vaccine series.
- Assessment of immunogenicity using geometric mean concentration (GMC) and seroprotection rate (SPR).
Main Results:
- High overall seroprotection rate (99.43%) and geometric mean concentration (986.36 mIU/mL).
- Infants with gestational age <28 weeks showed higher GMC (3,735.59 mIU/mL).
- Uniform vaccine schedules resulted in higher GMC (1,281.26 mIU/mL) compared to mixed schedules (691.91 mIU/mL).
Conclusions:
- Hepatitis B vaccination induces a robust immune response in preterm infants.
- Variations in antibody response magnitude may be linked to vaccine expression systems.
- Findings can inform optimized vaccination strategies for preterm populations.
Abstract:
The global rise in preterm infants presents specific challenges for hepatitis B prevention. Although hepatitis B vaccination is recommended, detailed understanding of immunogenicity patterns and influencing factors requires further investigation. We analyzed 699 preterm infants completing the hepatitis B vaccination series to assess immunogenicity via geometric mean concentration (GMC) and seroprotection rate (SPR). The regimen was highly immunogenic, with an overall SPR of 99.43% (GMC: 986.36 mIU/mL) and 95.28% of infants achieving high-level protection (anti-HBs ≥100 mIU/mL). Though SPR was consistently high across subgroups, notable GMC variations emerged: infants with gestational age <28 weeks markedly higher GMC (3,735.59 mIU/mL) than more mature subgroups. Statistically significant GMC differences were noted between immunization protocols, with uniform schedules yielding higher values (1,281.26 mIU/mL) than mixed approaches (691.91 mIU/mL; P < .001). Preterm infants of HBsAg-positive mothers maintained a high SPR (96.55%) despite a lower GMC (572.18 mIU/mL). This study confirms that hepatitis B vaccination induces a robust immune response at 1 to 2 months post-vaccination in preterm infants. Observed variations in antibody response magnitude related to vaccine expression system may inform optimization of initial vaccination strategies for preterm populations.
Related Concept Videos
Vaccinations
Hepatic Drug Excretion: Influencing Factors
Self-Efficacy
Transcription Factors
What is the Immune System?
Impact of Groups on Groups

